1Venge P, Johnston N, Lagerqvist B, et al. Clinical and analytical performance of the liaison cardiac troponin Ⅰ assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC - Ⅱ substudy[J]. Clin Chem,2003,49:880.
2Apple F S, Quist H E, Murakami M M. Diagnostic and Prognostic Value of Cardiac Troponin I Assays in Patients AdmiRed With Symptoms Suggestive of Acute Coronary Syndrome[J]. Arch Pathol Lab Med,2004, 128:430.
3Morrow D A, Rifai N,Sabatine M S.et al.Evaluation of the AccuTrd Cardiac Troponin I Assay for Risk Assessment in Acute Coronary Syndromes [J]. Clinical Chemistry,2003,49:1396.
1Pearson TA, Mensah GA, Hong Y, et al. CDC/AHA Workshop on markers of inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice : Overview. Circulation, 2004,110 : e543-544.
2Myers GL,Rifai N,Tracy RP,et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease : Application to Clinical and Public Health Practice: report from the laboratory science discussion group. Circulation ,200d, 110 :e545-549.
3Smith SC Jr, Anderson JL, Cannon RO 3rd, et al. CDC/AHA Workshop on Markers of inflammation and Cardiovascular Disease:Application to Clinical And Public Health Practice: report from the clinical practice discussion group. Circulation,2004, 110 : e550-553.
4Fortmann SP, Ford E, Criqui MH, et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease : Application to Clinical and Public Health Practice: report from the population science discussion group. Circulation,2004, 110 : e554-559.
5Biasucci LM, CDC, AHA. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease : Application to Clinical and Public Health practice: clinical use of inflammatory markers in Patients with cardiovascular diseases : a background paper.Circulation ,2004, 110 :e560-567.
6Wilson PW, CDC, AHA. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease:Application to Clinical and Public Health Practice: ability of inflammatory markers to predict disease in asymptomatic patients: a background paper. Circulation,2004,110:e568-571.
7Roberts WL, CDC, AHA. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease. Application to Clinical and Public Health Practice. laboratory tests available to assess inflammation-performance and standardization: a background paper.Circulation, 2004,110 :e572-578.
8Morrow DA, Braunwald E. Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy. Circulation, 2003,108:250-252.
9Apple FS. Clinical and analytical standardization issues confronting cardiac troponin I. Clin Chem, 1999,45:18-20.
10Alpert JS. Defining myocardial infarction:" will the real myocardial infarction please stand up ?" Am Heart J, 2003,146 : 377-379.
